Results
2303
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2303 companies
Orthofix Medical
Market Cap: US$450.2m
Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.
OFIX
US$11.30
7D
-1.8%
1Y
-21.8%
Sonida Senior Living
Market Cap: US$447.1m
Owns and operates senior housing communities in the United States.
SNDA
US$24.64
7D
-0.5%
1Y
-6.3%
Altimmune
Market Cap: US$446.9m
A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.
ALT
US$5.49
7D
-1.8%
1Y
-19.9%
kneat.com
Market Cap: CA$617.8m
Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.
KSI
CA$6.51
7D
-0.6%
1Y
49.3%
Oxford Biomedica
Market Cap: UK£330.7m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£3.12
7D
2.5%
1Y
-1.0%
Clarity Pharmaceuticals
Market Cap: AU$690.9m
A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.
CU6
AU$2.15
7D
-7.3%
1Y
-53.3%
Cross Country Healthcare
Market Cap: US$443.6m
Provides talent management services for healthcare clients in the United States.
CCRN
US$13.43
7D
-2.5%
1Y
-7.8%
Tilray Brands
Market Cap: US$443.1m
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
TLRY
US$0.45
7D
3.9%
1Y
-75.2%
Atai Life Sciences
Market Cap: US$442.7m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.
ATAI
US$2.31
7D
20.9%
1Y
41.7%
Zenas BioPharma
Market Cap: US$441.8m
A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.
ZBIO
US$9.23
7D
-15.6%
1Y
n/a
PureTech Health
Market Cap: UK£325.2m
Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
PRTC
UK£1.35
7D
0.3%
1Y
-40.7%
Senseonics Holdings
Market Cap: US$436.8m
A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.
SENS
US$0.53
7D
6.1%
1Y
20.6%
SIGA Technologies
Market Cap: US$434.4m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.09
7D
-0.7%
1Y
-17.7%
Bioventus
Market Cap: US$433.3m
A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.
BVS
US$6.53
7D
0.5%
1Y
-4.1%
Septerna
Market Cap: US$430.0m
A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.
SEPN
US$9.72
7D
7.3%
1Y
n/a
Oruka Therapeutics
Market Cap: US$428.3m
A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.
ORKA
US$11.47
7D
8.4%
1Y
n/a
Paragon Care
Market Cap: AU$662.1m
Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.
PGC
AU$0.40
7D
-2.4%
1Y
n/a
Healius
Market Cap: AU$657.2m
Provides specialty diagnostic services to consumer and practitioners in Australia.
HLS
AU$0.91
7D
-13.0%
1Y
-27.9%
MBX Biosciences
Market Cap: US$421.1m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.
MBX
US$12.52
7D
2.2%
1Y
n/a
Amylyx Pharmaceuticals
Market Cap: US$420.7m
A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.
AMLX
US$4.79
7D
-11.8%
1Y
186.8%
Development Technologies
Market Cap: US$420.0m
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.
DVTC
US$20.00
7D
0%
1Y
455.6%
Vitalhub
Market Cap: CA$579.0m
Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.
VHI
CA$10.20
7D
-0.9%
1Y
47.2%
Autolus Therapeutics
Market Cap: US$417.8m
A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.
AUTL
US$1.65
7D
12.2%
1Y
-59.0%
Knight Therapeutics
Market Cap: CA$577.8m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$5.76
7D
0%
1Y
-4.2%
Precigen
Market Cap: US$416.2m
A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$1.37
7D
3.8%
1Y
5.4%
NeuroPace
Market Cap: US$415.2m
Operates as a medical device company in the United States.
NPCE
US$12.46
7D
-31.3%
1Y
84.9%
Personalis
Market Cap: US$414.2m
Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
PSNL
US$4.70
7D
-0.4%
1Y
260.2%
Surmodics
Market Cap: US$412.0m
Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.
SRDX
US$29.20
7D
0.3%
1Y
-30.6%
Faron Pharmaceuticals Oy
Market Cap: UK£305.3m
Operates as a clinical stage drug discovery and development company.
FARN
UK£2.45
7D
9.9%
1Y
38.0%
ORIC Pharmaceuticals
Market Cap: US$410.9m
A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.
ORIC
US$5.97
7D
1.7%
1Y
-29.3%
MeiraGTx Holdings
Market Cap: US$409.1m
A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$5.10
7D
-3.8%
1Y
2.0%
Savara
Market Cap: US$408.7m
A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.
SVRA
US$2.14
7D
-26.6%
1Y
-48.6%
Sage Therapeutics
Market Cap: US$408.3m
A biopharmaceutical company, develops and commercializes brain health medicines.
SAGE
US$6.48
7D
-4.7%
1Y
-40.3%
CytoDyn
Market Cap: US$406.2m
A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.
CYDY
US$0.34
7D
-6.1%
1Y
38.7%
Zhengye Biotechnology Holding
Market Cap: US$405.7m
Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.
ZYBT
US$8.80
7D
-1.0%
1Y
n/a
Tectonic Therapeutic
Market Cap: US$402.3m
A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).
TECX
US$21.55
7D
-4.6%
1Y
n/a